From: Medication and psychotherapy in eating disorders: is there a gap between research and practice?
AN | AN-sub-threshold | BN | BN-sub-threshold | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|
(N = 44) | (N = 30) | (N = 126) | (N = 53) | (N = 253) | ||||||
N | % | N | % | N | % | N | % | N | % | |
No medication | 17 | 38.6 | 14 | 46.7 | 77 | 69.1 | 31 | 58.5 | 139 | 54.9 |
One psychiatric drug | 14 | 31.8 | 9 | 30 | 22 | 17.5 | 8 | 15.1 | 53 | 20.9 |
Two psychiatric drugs | 5 | 11.4 | 3 | 10.0 | 13 | 10.3 | 5 | 9.4 | 26 | 10.3 |
Three psychiatric drugs | 3 | 6.8 | 4 | 13.3 | 7 | 5.6 | 3 | 5.7 | 17 | 6.7 |
Four psychiatric drugs | 4 | 9.1 | 0 | 0 | 2 | 1.6 | 2 | 3.8 | 8 | 3.2 |
Five psychiatric drugs | 0 | 0 | 0 | 0 | 3 | 2.4 | 0 | 0 | 3 | 1.2 |
Total on any psychiatric medication | 26 | 59.0 | 16 | 53.3 | 41 | 32.5 | 25 | 47.2 | 108 | 42.7 |
Anti-anxiety | 7 | 15.9 | 5 | 16.7 | 12 | 9.5 | 6 | 11.3 | 36 | 14.2 |
Hypnotics | 0 | 0 | 0 | 0 | 4 | 3.2 | 2 | 3.8 | 6 | 2.4 |
Psycho-stimulants | 2 | 4.5 | 0 | 0 | 3 | 2.4 | 2 | 3.8 | 7 | 2.8 |
Tricyclic antidepressants | 1 | 2.3 | 0 | 0 | 1 | 0.8 | 1 | 1.9 | 3 | 1.2 |
SSRIs | 20 | 45.5 | 11 | 36.7 | 8 | 14.3 | 11 | 20.8 | 50 | 19.8 |
Fluoxetine | 4 | 9.1 | 5 | 16.7 | 4 | 3.2 | 2 | 3.8 | 15 | 5.9 |
SARIs | 2 | 4.5 | 0 | 0 | 3 | 2.4 | 0 | 0 | 5 | 2.0 |
SNRIs | 1 | 2.3 | 2 | 6.7 | 15 | 11.9 | 3 | 3.8 | 21 | 8.3 |
NaSSRAs | 1 | 2.3 | 1 | 3.3 | 4 | 3.2 | 1 | 1.9 | 7 | 2.8 |
NDRIs | 1 | 2.3 | 0 | 0 | 5 | 4.0 | 0 | 0 | 6 | 2.4 |
Melatonergic agonists | 0 | 0 | 0 | 0 | 1 | 0.8 | 0 | 0 | 1 | 0.4 |
Antidepressant (unspecified) | 1 | 2.3 | 0 | 0 | 0 | 0 | 1 | 1.9 | 2 | 0.8 |
Total on anti-depressants | 27 | 61.4 | 14 | 46.7 | 41 | 32.5 | 25 | 47.2 | 107 | 42.3 |
Mood stabilisers | 3 | 6.8 | 4 | 13.3 | 16 | 12.7 | 3 | 3.8 | 26 | 10.3 |
Antipsychotics | 7 | 15.9 | 2 | 6.7 | 8 | 6.3 | 4 | 7.5 | 21 | 8.3 |